Spontaneous bacterial peritonitis

From Citizendium
Revision as of 11:18, 6 September 2009 by imported>Robert Badgett
Jump to navigation Jump to search
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, spontaneous bacterial peritonitis (SB) is a form of peritonitis that occurs in patient with ascites.[1] Monomicrobial nonneutrocytic bacterascites is a positive culture for a pure growth of a single type of organism but the neutrophil count is less than 250 cells/mm3.[2] About a third of patients with monomicrobial nonneutrocytic bacterascites will progress to SBP.[2]

Etiology/cause

Proton pump inhibitors may be associated with SBP.[3]

Diagnosis

On physical examination, most patients have mild abdominal pain.[4]

The impression of the physician performing the physical examination may not be accurate:[4]

Regarding individual signs and symptoms:

Treatment

The role of antibiotics is not clear as "oral quinolones could be considered an option for those with less severe manifestations".[5]

Oral treatment

Randomized controlled trials of oral antibiotics for non-severe spontaneous bacterial peritonitis[6][7][8][9][10][11]
Trial Patients Comparison Outcome Results
Intervention Control
Grange[6]
2004
35 patients moxifloxacin versus amoxicillin-clavulanic acid cell cell cell
Tuncer[7]
2003
53 patients oral ciprofloxacin versus IV cefotaxime with IV ceftriaxone cell cell cell
Ricart[8]
2000
48 patients oral amoxicillin-clavulanic acid for an average of 2.6 days then orallly for an average of 5.6 days versus cefotaxime IV for an average of 8 days cell cell cell
Terg[9]
1997
80 patients ciprofloxacin IV for two days then oral for 5 days versus ciprofloxacin IV for seven days cell cell cell
Figueiredo[10]
1996
38 patients oral cefixime versus IV ceftriaxone cell cell cell
Navasa[11]
1996
123 patients oral ofloxacin versus IV cefotaxime cell cell cell

References

  1. ICD9: 567.23
  2. 2.0 2.1 Runyon BA (1990). "Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis.". Hepatology 12 (4 Pt 1): 710-5. PMID 2210672.
  3. Bajaj JS, Zadvornova Y, Heuman DM, et al. (May 2009). "Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites". Am. J. Gastroenterol. 104 (5): 1130–4. DOI:10.1038/ajg.2009.80. PMID 19337238. Research Blogging.
  4. 4.0 4.1 Chinnock B, Afarian H, Minnigan H, Butler J, Hendey GW (September 2008). "Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis". Ann Emerg Med 52 (3): 268–73. DOI:10.1016/j.annemergmed.2008.02.016. PMID 18433932. Research Blogging.
  5. Chavez-Tapia NC, Soares-Weiser K, Brezis M, Leibovici L (2009). "Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients". Cochrane Database Syst Rev (1): CD002232. DOI:10.1002/14651858.CD002232.pub2. PMID 19160207. Research Blogging.
  6. 6.0 6.1 Grange J. Randomized, comparative study of moxifloxacin versus amoxicillin-clavulanate in the treatment of bacterial infections in cirrhotic patients. Hepatology 2004;40(4 (Suppl 1)):631A.
  7. 7.0 7.1 Tuncer I, Topcu N, Durmus A, Turkdogan MK (2003 Sep-Oct). "Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.". Hepatogastroenterology 50 (53): 1426-30. PMID 14571754.
  8. 8.0 8.1 Ricart E, Soriano G, Novella MT, Ortiz J, Sàbat M, Kolle L et al. (2000). "Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.". J Hepatol 32 (4): 596-602. DOI:10.1016/S0168-8278(00)80221-4. PMID 10782908. Research Blogging.
  9. 9.0 9.1 Terg R, Cobas S, Fassio E, Landeira G, Ríos B, Vasen W et al. (2000). "Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.". J Hepatol 33 (4): 564-9. PMID 11059861.
  10. 10.0 10.1 Figueiredo FAF, Coelho HSM, Soares JAS, Salgueiro E, Pinto CA. Oral cephalosporin for the treatment of non-severe spontaneous bacterial peritonitis in liver disease: a prospective study of 38 cases [Cefalosporina oral para o tratamento da peritonite bacteriana espontanea nao complicada na cirrose hepatica: um estudo prospectivo de 38 casos]. GED - Gastrenterologia-Endoscopia-Digestiva 1997;16(6):231-6.
  11. 11.0 11.1 Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, et al.Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996;111(4):1011-7. DOI:10.1016/S0016-5085(96)70069-0